Monte Rosa Therapeutics, Inc. - GLUE
All tracked SEC files for this issuer. Showing up to 200 latest records.
Need parsed ownership details (13D/13G with shares/percent)?
Open ownership details
Form 4 = insider transactions report. Form 144 = notice of proposed sale (not a completed trade confirmation).
Files summary
Total files loaded: 43
Latest filed: Apr 16, 2026
| Form | Count |
|---|---|
| 4 | 14 |
| 144 | 12 |
| 8-K | 7 |
| SCHEDULE 13G/A | 6 |
| SCHEDULE 13D/A | 3 |
| 144/A | 1 |
Latest files
| Filed | Form | Report period | Accession | SEC |
|---|---|---|---|---|
| Apr 16, 2026 | 144 | — | 0001950047-26-003550 | View |
| Apr 15, 2026 | 4 | Apr 14, 2026 | 0001193125-26-156981 | View |
| Apr 14, 2026 | 144 | — | 0001950047-26-003455 | View |
| Apr 13, 2026 | 144 | — | 0001950047-26-003392 | View |
| Apr 10, 2026 | 4 | Apr 09, 2026 | 0001193125-26-151254 | View |
| Apr 09, 2026 | 144 | — | 0001950047-26-003347 | View |
| Apr 08, 2026 | 144 | — | 0001950047-26-003308 | View |
| Apr 07, 2026 | 4 | Apr 06, 2026 | 0001193125-26-145545 | View |
| Mar 19, 2026 | SCHEDULE 13D/A | — | 0001072613-26-000294 | View |
| Mar 17, 2026 | 8-K | Mar 17, 2026 | 0001193125-26-109353 | View |
| Mar 05, 2026 | 4 | Mar 04, 2026 | 0001193125-26-094296 | View |
| Mar 04, 2026 | 144 | — | 0001193125-26-091704 | View |
| Mar 04, 2026 | 4 | Mar 02, 2026 | 0001193125-26-091733 | View |
| Mar 02, 2026 | 144 | — | 0001950047-26-001966 | View |
| Mar 02, 2026 | 144 | — | 0001965301-26-000022 | View |
| Mar 02, 2026 | 4 | Feb 27, 2026 | 0001193125-26-085677 | View |
| Feb 27, 2026 | 144 | — | 0001950047-26-001887 | View |
| Feb 24, 2026 | 4 | Feb 23, 2026 | 0001193125-26-066955 | View |
| Feb 23, 2026 | 144 | — | 0001950047-26-001676 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | — | 0001104659-26-016412 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | — | 0000921895-26-000461 | View |
| Feb 10, 2026 | 8-K | Feb 09, 2026 | 0001193125-26-044616 | View |
| Jan 21, 2026 | SCHEDULE 13G/A | — | 0001012975-26-000062 | View |
| Jan 09, 2026 | SCHEDULE 13D/A | — | 0001193125-26-008951 | View |
| Jan 09, 2026 | 4 | Jan 07, 2026 | 0001193125-26-008902 | View |
| Jan 09, 2026 | 8-K | Jan 08, 2026 | 0001193125-26-009005 | View |
| Jan 08, 2026 | 144/A | — | 0001965301-26-000002 | View |
| Jan 07, 2026 | 8-K | Jan 07, 2026 | 0001193125-26-005420 | View |
| Jan 07, 2026 | 8-K | Jan 07, 2026 | 0001193125-26-006341 | View |
| Jan 07, 2026 | 144 | — | 0001965301-26-000001 | View |
| Jan 05, 2026 | 144 | — | 0001193125-26-002369 | View |
| Jan 05, 2026 | 4 | Jan 02, 2026 | 0001193125-26-002385 | View |
| Jan 05, 2026 | 4 | Jan 02, 2026 | 0001193125-26-002386 | View |
| Jan 05, 2026 | 4 | Jan 02, 2026 | 0001193125-26-002389 | View |
| Jan 05, 2026 | 4 | Jan 05, 2026 | 0001193125-26-002390 | View |
| Jan 05, 2026 | 4 | Jan 02, 2026 | 0001193125-26-002401 | View |
| Jan 05, 2026 | 4 | Jan 02, 2026 | 0001193125-26-002406 | View |
| Dec 16, 2025 | 8-K | Dec 16, 2025 | 0001193125-25-319981 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | — | 0000902664-25-004946 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | — | 0000080255-25-000838 | View |
| Nov 12, 2025 | SCHEDULE 13D/A | — | 0001193125-25-277603 | View |
| Nov 06, 2025 | 8-K | Nov 06, 2025 | 0001193125-25-268042 | View |
| Oct 31, 2025 | SCHEDULE 13G/A | — | 0000102909-25-000255 | View |